Lessons from Illicit Gene Editing, Fake News in Medicine & More: December 2018 VOICE Digest
The Holiday Season is once again upon us, and we want to take this opportunity to wish all of our readers, whether patients, colleagues or friends, a Festive Chanukah, a Merry Christmas and a Delightful Kwanzaa. All denominations we wish a Healthy, Happy and Prosperous New Year 2019, and our active patients in treatment all around the world, we wish that 2019 may bring you the desired pregnancies and deliveries many of you have been waiting for, for much too long. On behalf of all CHR staff members, we promise to do our best to be of help.
CHR will be closing 2018 with at least 24 peer-reviewed published communications and, therefore, with another record year in research activity. We also want to take this opportunity to thank all of our academic collaborators, and especially Prof. Ali Brivanlou, PhD and the staff of his laboratory at Rockefeller University here in NYC; Prof. Juan Carlos Izpisua Belmonte, PhD from the Salk Institute for Biological Studies in La Jolla, CA; Assist. Prof. Aritro Sen, now having established his own laboratory at Michigan State University in East Lansing, MI; Evelyn Telfer, PhD from the Institute of Cell Biology and Centre for Integrative Physiology at the School of Biological Sciences of the University of Edinburgh, Scotland, UK and Prof. Dr. Peter Husslein and his departmental staff at Vienna University, Vienna, Austria (especially CHR’s longtime collaborator, Assoc. Prof. Andrea Weghofer, MD, PhD, MS, MBA), and wish all of them a Festive Holiday Season and a Wonderful 2019.
Finally, our best wishes and a big thank-you also goes to the many colleagues from all over the world who during 2018 have come to visit CHR for periods of varying length. Though the primary purpose of their visits was always to learn from CHR, there was hardly a visitor from whom we did not learn in return at the same time. We are delighted that our center’s recent expansion offers us now more space to welcome visitors on the clinical as well as on the laboratory side of our enterprise, and we are looking forward to an even larger number of visitors in 2019.
In this issue of the CHR VOICE, we cover:
- Lessons from the illicit use of CRISPR- Cas9 germline editing of human embryos in China
- “Fake news" in medicine: How much trust can we have in the medical information we receive?
- Why egg quality can be even more important than embryo quality
- CHR offers free IVF cycles to women who have mitochondrial diseases
- CHR in the media
- What is DHEA: Back to the basics
- What is CoQ10: Back to the basics
Read the December 2018 CHR VOICE in PDF.
Norbert Gleicher, MD, FACOG, FACS
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over
17,800 babies into the world.
DISCOVER YOUR TREATMENT OPTIONS